CTOs on the Move

CIC Health

www.cic-health.com

 
CIC Health provides COVID-19 testing services to organizations and individuals. We simplify testing by integrating CLIA-certified laboratories, physician oversight, result reporting, and billing software. Whether a one-time test or routine testing for a business, school, care facility, or consumers, our services are accessible, fast, and easy.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Vinay Gidwaney
Head of Technology Profile

Similar Companies

PMG of Santa Cruz

PMG of Santa Cruz is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Santa Cruz, CA. To find more information about PMG of Santa Cruz, please visit www.pmgscc.com

Greenbriar Treatment Center

Greenbriar offers Home Study Courses accredited for certification of alcohol and drug counselors. These courses provide the information, and the CEUs, you will need as a certified addictions counselor.

Office of the National Coordinator for Health Information Technology

The Office of the National Coordinator for Health Information Technology (ONC) is the lead agency charged with formulating the federal government’s health IT strategy and coordinating federal health IT policies, standards, programs, and investments. ONC is organizationally located within the Office of the Secretary for the U.S. Department of Health and Human Services (HHS). The position of National Coordinator was created in 2004, through an Executive Order, and legislatively mandated in the Health Information Technology for Economic and Clinical Health Act (HITECH Act) of 2009.

Let Medical Systems

Let Medical Systems is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.